Application of DWI in Diagnosis of Prostate Cancer
NCT04962269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103
Last updated 2021-07-14
Summary
This study compared the performance of different models of multiple b-value DWI in diagnosing prostate cancer.
Conditions
- Prostate Cancer
- Benign Prostatic Hyperplasia
Interventions
- DIAGNOSTIC_TEST
-
MRI
monoexponential model, intravoxel incoherent motion (IVIM) model and stretched exponential model
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Jianyu Liu · Peking University
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-12
- Primary Completion
- 2018-06-21
- Completion
- 2018-06-21
More Related Trials
-
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
NCT06126172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection
NCT03572946 ·Status: UNKNOWN ·Phase: NA
-
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
NCT06612047 ·Status: RECRUITING
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection
NCT04124107 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer
NCT06584279 ·Status: RECRUITING
-
An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer
NCT05047965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Magnetic Resonance Imaging to Evaluate Prostate Cancer
NCT00182624 ·Status: COMPLETED
-
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
NCT06946771 ·Status: RECRUITING
-
68Ga-XACP3 PET/CT in Prostate Cancer
NCT07242014 ·Status: RECRUITING ·Phase: NA
-
CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr
NCT02689271 ·Status: COMPLETED
-
68Ga-PSMA PET in the Prostate Cancer
NCT04967001 ·Status: RECRUITING ·Phase: NA
-
Clinical Application of 68Ga-PSMA PET in Prostate Cancer
NCT03650946 ·Status: UNKNOWN
-
Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging
NCT00611065 ·Status: WITHDRAWN ·Phase: NA
-
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
NCT06575361 ·Status: COMPLETED ·Phase: NA
-
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening
NCT04322045 ·Status: UNKNOWN ·Phase: NA
-
Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study
NCT05025527 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3
NCT04573179 ·Status: UNKNOWN
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
NCT05024162 ·Status: RECRUITING ·Phase: NA
-
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL
NCT04317625 ·Status: UNKNOWN ·Phase: NA
-
Super-fast 3T Prostate MRI Using High Gradient Strength and Deep Learning
NCT06244680 ·Status: COMPLETED
-
The Development and Validation of MRI-AI-based Predictive Models for csPCa
NCT06842264 ·Status: RECRUITING
-
Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy
NCT04685928 ·Status: COMPLETED ·Phase: NA